Jean Dubé

Dr. Jean Dubé

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2020 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
TCThierry Chénard
Thierry Chénard
MMMandy Malick
Mandy Malick
JDJean Dubé
Jean Dubé
EMEric Masse
Eric Masse
Background: Colorectal cancer (CRC) is one of the prevailing causes of cancer mortality in the world. A common screening test for CRC is based on the human hemoglobin immunochemical based fecal occult blood test (iFOBT), which consists in the detection of blood in the patient’s stool. In addition to iFOBT, recent studies support the use of the gut microbiome as a biomarker for CRC prediction. However, these studies did not take into account the effect of blood itself on the microbiome composition, independently of CRC. Therefore, we investigated the microbiome of patients undergoing the iFOBT screening in order to determine the effect of blood alone. Our cohort consisted of patients who had no blood in their stools (n = 265) or did have blood but no underlying precancerous or cancerous lesions (n = 235). We also identified bacterial taxa specifically associated with the presence of blood in stools. Results: We observed significant differences in the intestinal bacterial composition that could be solely caused by the presence of blood in stools. More precisely, we identified 12 bacterial species showing significant differences in abundance between both our study groups. These species, Bacteroides uniformis, Collinsella aerofaciens, Eggerthella lenta and Clostridium symbiosum demonstrated increased abundance in the presence of blood. In contrast, the species Prevotella copri, Coprococcus eutactus and catus, Faecalibacterium prausnitzii, Roseburia faecis, Blautia obeum, Gemmiger formicilis and Clostridium celatum showed decreased abundance in patients with blood in their stools. Notably, we found multiple taxa that were reported in previous studies linking microbiome composition and diseases. Conclusions: We show that, in the absence of disease, blood in the stools has a major influence on the composition of the microbiome. Our data suggest that blood itself should be taken into consideration when investigating the microbiome signatures of intestinal diseases.

21 August 2020 in Vaccines
Verified
Journal Article
Open access
PDF file
TCThierry Chénard
Thierry Chénard
KPKarine Prévost
Karine Prévost
JDJean Dubé
Jean Dubé
EMEric Masse
Eric Masse
The gut microbiota, which consists of all bacteria, viruses, fungus, and protozoa living in the intestine, and the immune system have co-evolved in a symbiotic relationship since the origin of the immune system. The bacterial community forming the microbiota plays an important role in the regulation of multiple aspects of the immune system. This regulation depends, among other things, on the production of a variety of metabolites by the microbiota. These metabolites range from small molecules to large macro-molecules. All types of immune cells from the host interact with these metabolites resulting in the activation of different pathways, which result in either positive or negative responses. The understanding of these pathways and their modulations will help establish the microbiota as a therapeutic target in the prevention and treatment of a variety of immune-related diseases.

6 August 2019 in Autism Research
Verified
Journal Article
Closed access
SBSérine Benachenhou
Sérine Benachenhou
AEAntoine Etcheverry
Antoine Etcheverry
LGLuc Galarneau
Luc Galarneau
JDJean Dubé
Jean Dubé
AÇArtuela Çaku
Artuela Çaku

1 May 2005 in Clinical Biochemistry
Verified
Journal Article
Closed access
JDJean Dubé
Jean Dubé
JGJoel Girouard
Joel Girouard
PLPierre Leclerc
Pierre Leclerc
PDPierre Douville
Pierre Douville

1 May 2021 in Journal of Obstetrics and Gynaecology Canada
Verified
Journal Article
Closed access
CTCamille Tourigny
Camille Tourigny
EREvelyne Rey
Evelyne Rey
JMJulie Moreau
Julie Moreau
MGMarie-Odile Guimond
Marie-Odile Guimond
AOAnnie Ouellet
Annie Ouellet
ACAnne-Marie Côté
Anne-Marie Côté

1 January 2021 in Clinical Biochemistry
Verified
Journal Article
Closed access
BDBenoit Denhez
Benoit Denhez
LWLi Wang
Li Wang
JMJulie Moreau
Julie Moreau
JDJean Dubé
Jean Dubé
ACAnne-Marie Côté
Anne-Marie Côté